Telmisartan lowers home blood pressure and improves insulin resistance without correlation between their changes.

Clinical and experimental hypertension (New York, N.Y. : 1993)

Volumn 33, Issue 2, 2011, Pages 100-105

  Kobayashi, Kazuhiro ^a   Ohno, Yoichi ^b   Takenaka, Tsuneo ^b   Ikeda, Naofumi ^b   Okada, Hirokazu ^b   Kanno, Yoshihiko ^b   Suzuki, Hiromichi ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; INSULIN; LIPID; TELMISARTAN;

AGED; ARTICLE; BLOOD; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; BENZOATES; BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; LIPIDS; MIDDLE AGED;

EID: 79960626427     PISSN: None     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2010.531834     Document Type: Article

References (0)